Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection

In the published article, there was an error in the affiliations. Instead of three, there are only two affiliations. The original affiliation 2 was removed. The correct affiliations are listed below:

Instead of

Yan Yan¹, Yuanwang Qiu¹, Chantsalmaa Davgadorj¹, Chunfu Zheng^2,3

• “¹Laboratory for Infection and Immunity, Hepatology Institute of Wuxi, The Fifth People’s Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China.

• ²Department of Immunology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.

• ³Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.”, it should be

Yan Yan¹, Yuanwang Qiu¹, Chantsalmaa Davgadorj¹, Chunfu Zheng²

• “¹Laboratory for Infection and Immunity, Hepatology Institute of Wuxi, The Fifth People’s Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China.

• ²Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Summary

Keywords

HBV, TLR, carcinogenesis, signaling pathway, therapeutics, infection

Citation

Yan Y, Qiu Y, Davgadorj C and Zheng C (2023) Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection. Front. Cell. Infect. Microbiol. 13:1253110. doi: 10.3389/fcimb.2023.1253110

Received

04 July 2023

Accepted

06 July 2023

Published

21 July 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2023

Updates

Check for updates

Copyright

© 2023 Yan, Qiu, Davgadorj and Zheng.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yan Yan, yanyan198134@hotmail.com; Chunfu Zheng, zheng.alan@hotmail.com

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.